These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6469432)
1. Isometric exercise before and after nadolol treatment in uncomplicated essential hypertension. Corea L; Bentivoglio M; Provvidenza M Int J Clin Pharmacol Res; 1984; 4(1):35-40. PubMed ID: 6469432 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide]. Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657). Costa FV; Borghi C; Boschi S; Ambrosioni E Int J Clin Pharmacol Res; 1984; 4(5):373-9. PubMed ID: 6151553 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients. Orlandi C; Fogari R Clin Ther; 1983; 5(6):632-7. PubMed ID: 6627289 [TBL] [Abstract][Full Text] [Related]
5. Short-term isometric exercise reduces systolic blood pressure in hypertensive adults: possible role of reactive oxygen species. Peters PG; Alessio HM; Hagerman AE; Ashton T; Nagy S; Wiley RL Int J Cardiol; 2006 Jun; 110(2):199-205. PubMed ID: 16239039 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of ketanserin during cold pressure and during isometric and dynamic exercise in hypertensive patients. Hedner T; Andersson OK; Pettersson A; Persson B J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S73-7. PubMed ID: 2446077 [TBL] [Abstract][Full Text] [Related]
7. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate]. Weth G; Schneider J; Rodatz H; Haubitz I Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733 [TBL] [Abstract][Full Text] [Related]